BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35963422)

  • 1. Co-existing polysaccharides affect the systemic exposure of major bioactive ingredients in Chang-Kang-Fang, a multi-herb prescription for treatment of irritable bowel syndrome.
    Zhong P; Zhou J; Fan YT; Guo MF; Zhu H; Zhou SS; Zhu JH; Zhang HH; Zhou GR; Miao XL; Li SL; Mao Q
    J Ethnopharmacol; 2022 Nov; 298():115601. PubMed ID: 35963422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical profiles and pharmacological activities of Chang-Kang-Fang, a multi-herb Chinese medicinal formula, for treating irritable bowel syndrome.
    Mao Q; Shi L; Wang ZG; Luo YH; Wang YY; Li X; Lu M; Ju JM; Xu JD; Kong M; Zhou SS; Shen MQ; Li SL
    J Ethnopharmacol; 2017 Apr; 201():123-135. PubMed ID: 28263849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-κB/NLRP3 pathway.
    Zhang S; Tian D; Xia Z; Yang F; Chen Y; Yao Z; He Y; Miao X; Zhou G; Yao X; Tang J
    J Ethnopharmacol; 2024 Aug; 330():118236. PubMed ID: 38670405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Chang-Kang-Fang Formula on the Microbiota-Gut-Brain Axis in Rats With Irritable Bowel Syndrome.
    Ling X; Peng S; Zhong J; Guo L; Xu Y; Jin X; Chu F
    Front Pharmacol; 2022; 13():778032. PubMed ID: 35614949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating multiple-chromatographic approaches to evaluate chemical consistency of Chang-Kang-Fang preparations from mixed-herb decoction and combined single-herb decoction.
    Fan YT; Zhong P; Xu JD; Zhou SS; Kong M; Zhou GR; Mao Q; Li SL
    J Pharm Biomed Anal; 2021 Sep; 203():114186. PubMed ID: 34118572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effectiveness and mechanism of action of the Chang-Kang-Fang formula combined with bifid triple viable capsules on diarrhea-predominant irritable bowel syndrome.
    Sun J; Zhang M; Liu W; Liu Y; Zhang D; Fan X; Zhang J; Li T; Lu M
    Front Microbiol; 2023; 14():1160783. PubMed ID: 37440881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering chemical and metabolite profiling of Chang-Kang-Fang by UPLC-Q-TOF-MS/MS and its potential active components identification.
    Yang F; Zhang S; Tian D; Zhou G; Tang X; Miao X; He Y; Yao X; Tang J
    Chin J Nat Med; 2023 Jun; 21(6):459-480. PubMed ID: 37407177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sensitive UPLC-MS/MS method for simultaneous determination of eleven bioactive components of Tong-Xie-Yao-Fang decoction in rat biological matrices.
    Li TX; Hu L; Zhang MM; Sun J; Qiu Y; Rui JQ; Yang XH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():90-100. PubMed ID: 24295908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-polysaccharide/herb interactions and compatibility rationality of Sijunzi decoction based on comprehensive pharmacokinetic screening for multi-components in rats with spleen deficiency syndrome.
    Dong B; Ma P; Chen X; Peng Y; Peng C; Li X
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115871. PubMed ID: 36309112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota.
    Jia F; Du L; He J; Zhang Z; Hou X; Dong Q; Bian Z; Zhao L
    J Ethnopharmacol; 2024 Sep; 331():118256. PubMed ID: 38677571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of bioactive components of Radix Angelicae Sinensis-Radix Paeoniae Alba herb couple in rat plasma and tissues by UPLC-MS/MS and its application to pharmacokinetics and tissue distribution.
    Luo N; Li Z; Qian D; Qian Y; Guo J; Duan JA; Zhu M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 963():29-39. PubMed ID: 24927419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Tong Xie Yao Fang on endogenous metabolites in urine of irritable bowel syndrome model rats.
    Zhao XY; Wang JW; Yin Y; Li K; Zhang M; Yan FP
    World J Gastroenterol; 2019 Sep; 25(34):5134-5151. PubMed ID: 31558862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Da-Jian-Zhong decoction alleviates diarrhea-predominant irritable bowel syndrome via modulation of gut microbiota and Th17/Treg balance.
    Zhang MM; Dang M; Wu X; Ou L; Li M; Zhao CB; Wei PF; Dong TW; Li Y; Wu CJ
    J Ethnopharmacol; 2024 Sep; 331():118275. PubMed ID: 38729534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic difference of berberine between normal and chronic visceral hypersensitivity irritable bowel syndrome rats and its mechanism.
    Gong Z; Chen Y; Zhang R; Yang Q; Wang Y; Guo Y; Zhou B; Weng X; Liu X; Li Y; Zhu X; Dong Y
    Arch Pharm Res; 2015 Oct; 38(10):1888-96. PubMed ID: 25716428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic comparisons by UPLC-MS/MS of isomer paeoniflorin and albiflorin after oral administration decoctions of single-herb Radix Paeoniae Alba and Zengmian Yiliu prescription to rats.
    Gong C; Yang H; Wei H; Qi C; Wang CH
    Biomed Chromatogr; 2015 Mar; 29(3):416-24. PubMed ID: 25042570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics of seven bioactive components after oral administration of crude and processed Qixue Shuangbu Prescription in chronic heart failure rats by microdialysis combined with UPLC-MS/MS.
    Chen L; Wei N; Jiang Y; Yuan C; Xu L; Li J; Kong M; Chen Y; Wang Q
    J Ethnopharmacol; 2023 Mar; 303():116035. PubMed ID: 36513265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetics of six major bioactive components in normal and type 2 diabetic rats after oral administration of Sanhuang Xiexin Decoction extracts by UPLC-TQ MS/MS.
    Wei XY; Tao JH; Cui X; Jiang S; Qian DW; Duan JA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():248-255. PubMed ID: 28756356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of calycosin-7-O-β-D-glucoside, cinnamic acid, paeoniflorin and albiflorin in rat plasma by UHPLC-MS/MS and its application to a pharmacokinetic study of Huangqi Guizhi Wuwu Decoction.
    Guan J; Wang L; Jin J; Chang S; Xiao X; Feng B; Zhu H
    J Pharm Biomed Anal; 2019 Jun; 170():1-7. PubMed ID: 30897430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the synergistic network regulation of active components from SiNiSan against irritable bowel syndrome via a comprehensive strategy: Combined effects of synephrine, paeoniflorin and naringin.
    Cai T; Wang X; Li B; Xiong F; Wu H; Yang X
    Phytomedicine; 2021 Jun; 86():153527. PubMed ID: 33845366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of essential oils from Xiang-Fu-Si-Wu Decoction on its non-volatile components and its application for pharmacokinetics in normal rats.
    Pan Y; Qian D; Liu P; Zhang Y; Zhu Z; Zhang L; Duan JA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():221-230. PubMed ID: 28628837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.